CONGENITAL DYSERYTHROPOIETIC ANAEMIA | New Study Highlights Endocrine Complications
A study published in the journal Hemoglobin on 30 September 2026 highlights the importance of monitoring endocrine health and iron burden in people living with congenital dyserythropoietic anaemia (CDA), including those who do not require regular blood transfusions.
Researchers reviewed the records of 12 patients aged 6–49 years. Nine had endocrine abnormalities, including low bone mineral density, diabetes, subclinical hypothyroidism, and elevated prolactin levels. Ten of the 12 patients were not transfusion-dependent. The researchers also reported an association between iron overload and endocrine complications.
The authors recommend regular endocrine evaluation and careful monitoring of iron burden as part of comprehensive CDA care. Their findings draw attention to complications that may require assessment alongside the management of anaemia.
Despite its small sample and retrospective design, the study adds to the limited evidence on this rare anaemia. Larger studies are needed to confirm the findings and assess their relevance to a broader patient population.
Source: Endocrine Complications in Patients with Congenital Dyserythropoietic Anemia: A Single-Center Cohort Study — published in Hemoglobin
